Max Berrill

865 total citations · 1 hit paper
14 papers, 639 citations indexed

About

Max Berrill is a scholar working on Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Max Berrill has authored 14 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 3 papers in Critical Care and Intensive Care Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Max Berrill's work include Cardiovascular Function and Risk Factors (7 papers), Cardiac Valve Diseases and Treatments (5 papers) and Vitamin C and Antioxidants Research (3 papers). Max Berrill is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Cardiac Valve Diseases and Treatments (5 papers) and Vitamin C and Antioxidants Research (3 papers). Max Berrill collaborates with scholars based in United Kingdom, Italy and United States. Max Berrill's co-authors include Ruben Manuel Luciano Colunga Biancatelli, Paul E. Marik, John D. Catravas, Aigul Baltabaeva, Isaac John, David Fluck, Pankaj Sharma, Ian Beeton and Jonathan Belsey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Max Berrill

13 papers receiving 608 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)

2020 382 citations Ruben Manuel Luciano Colunga Biancatelli, Max Berrill et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Berrill United Kingdom	5	189	177	98	79	69	14	639
Ruben Manuel Luciano Colunga Biancatelli United States	18	195 1.0×	260 1.5×	310 3.2×	84 1.1×	77 1.1×	31	1.1k
Manne Munikumar India	16	149 0.8×	134 0.8×	229 2.3×	40 0.5×	47 0.7×	44	725
Alexander Bertuccioli Italy	15	110 0.6×	122 0.7×	236 2.4×	86 1.1×	80 1.2×	67	824
Mohammed Iddir Luxembourg	11	251 1.3×	172 1.0×	197 2.0×	61 0.8×	28 0.4×	12	911
Helda Tutunchi Iran	24	214 1.1×	80 0.5×	435 4.4×	74 0.9×	98 1.4×	87	1.7k
Giulia Dingeo France	5	205 1.1×	171 1.0×	167 1.7×	27 0.3×	25 0.4×	6	721
Hira Shakoor United Arab Emirates	9	207 1.1×	108 0.6×	86 0.9×	58 0.7×	35 0.5×	21	624
Sofía Sosa Portugal	2	166 0.9×	169 1.0×	91 0.9×	22 0.3×	22 0.3×	4	545
Somia Iqtadar Pakistan	9	48 0.3×	143 0.8×	53 0.5×	40 0.5×	37 0.5×	34	405
Ebrahim Abbasi Oshaghi Iran	18	88 0.5×	102 0.6×	179 1.8×	62 0.8×	136 2.0×	70	972

Countries citing papers authored by Max Berrill

Since Specialization

Citations

This map shows the geographic impact of Max Berrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Berrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Berrill more than expected).

Fields of papers citing papers by Max Berrill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Berrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Berrill. The network helps show where Max Berrill may publish in the future.

Co-authorship network of co-authors of Max Berrill

This figure shows the co-authorship network connecting the top 25 collaborators of Max Berrill. A scholar is included among the top collaborators of Max Berrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Berrill. Max Berrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Berrill, Max. (2024). Discussion forum—EVAREST trial. European Heart Journal - Cardiovascular Imaging. 26(1). 184–184. 1 indexed citations

Berrill, Max, David Fluck, Isaac John, et al.. (2022). Tricuspid Regurgitation in Acute Heart Failure: Predicting Outcome Using Novel Quantitative Echocardiography Techniques. Diagnostics. 13(1). 109–109. 2 indexed citations

Berrill, Max, David Fluck, Isaac John, et al.. (2022). Right Ventricular Dysfunction Predicts Outcome in Acute Heart Failure. Frontiers in Cardiovascular Medicine. 9. 911053–911053. 3 indexed citations

Berrill, Max, et al.. (2021). Chest radiograph characteristics in COVID-19 infection and their association with survival. European Journal of Radiology Open. 8. 100360–100360. 4 indexed citations

Belsey, Jonathan, et al.. (2021). Right ventricular ejection fraction as predictor of outcome in acute heart failure using RV ellipsoid model: A retrospective analysis of a prospective cross-sectional study. SHILAP Revista de lepidopterología. 10. 4056102295–4056102295. 3 indexed citations

Berrill, Max, Ian Beeton, David Fluck, et al.. (2021). DISPROPORTIONATE MITRAL REGURGITATION DETERMINES SURVIVAL IN ACUTE HEART FAILURE. Journal of the American College of Cardiology. 77(18). 740–740. 1 indexed citations

Berrill, Max, Ian Beeton, David Fluck, et al.. (2021). Disproportionate Mitral Regurgitation Determines Survival in Acute Heart Failure. Frontiers in Cardiovascular Medicine. 8. 742224–742224. 2 indexed citations

Berrill, Max, et al.. (2021). Proportionality of tricuspid regurgitation determines outcome in acute heart failure. European Heart Journal. 42(Supplement_1). 1 indexed citations

Belsey, Jonathan, et al.. (2021). Right ventricular ejection fraction as predictor of outcome in acute heart failure using RV ellipsoid model. A retrospective analysis of a prospective cross-sectional study. European Heart Journal. 42(Supplement_1).

10.

Biancatelli, Ruben Manuel Luciano Colunga, et al.. (2020). Melatonin for the treatment of sepsis: the scientific rationale. Journal of Thoracic Disease. 12(S1). S54–S65. 74 indexed citations

11.

Biancatelli, Ruben Manuel Luciano Colunga, Max Berrill, John D. Catravas, & Paul E. Marik. (2020). Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Frontiers in Immunology. 11. 1451–1451. 382 indexed citations breakdown →

12.

Berrill, Max, et al.. (2020). Chest radiographs may assist in predicting the outcome in the early phase of Covid-19. UK district general hospital experience of Covid-19 first wave. Expert Review of Respiratory Medicine. 15(4). 537–541. 8 indexed citations

13.

Berrill, Max. (2020). Evaluation of Oxygenation in 129 Proning Sessions in 34 Mechanically Ventilated COVID-19 Patients. Journal of Intensive Care Medicine. 36(2). 229–232. 14 indexed citations

14.

Biancatelli, Ruben Manuel Luciano Colunga, Max Berrill, & Paul E. Marik. (2019). The antiviral properties of vitamin C. Expert Review of Anti-infective Therapy. 18(2). 99–101. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact